Outpost Medicine is a company committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. Its lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).
|HQ||Indianapolis, IN, US||Map|
|Employees (est.) (Nov 2021)||2|
Outpost Medicine total Funding
Outpost Medicine latest funding size
Time since last funding
|4 years ago|
Outpost Medicine investors
|Adams Street Partners, Takeda Ventures, Takeda Pharmaceutical, Vivo Capital, Frazier Healthcare Partners, Novo A/S|
When was Outpost Medicine founded?
Outpost Medicine was founded in 2016.
Who are Outpost Medicine key executives?
Outpost Medicine's key executives are Gordon McMurray, Scott Byrd and Ian Mills.
How many employees does Outpost Medicine have?
Outpost Medicine has 2 employees.
Who are Outpost Medicine competitors?
Competitors of Outpost Medicine include VITRUVIAN BioMedical, Hetero and WuXi Biologics.
Where is Outpost Medicine headquarters?
Outpost Medicine headquarters is located at 10401 N Meridian St #225, Indianapolis.
Where are Outpost Medicine offices?
Outpost Medicine has offices in Indianapolis and London.
How many offices does Outpost Medicine have?
Outpost Medicine has 2 offices.
Receive alerts for 300+ data fields across thousands of companies